Filing Details

Accession Number:
0001225208-18-012323
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-06 15:19:23
Reporting Period:
2018-08-03
Accepted Time:
2018-08-06 15:19:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
78003 Pfizer Inc PFE Pharmaceutical Preparations (2834) 135315170
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1678459 R Alexander Mackenzie Pfizer Inc.-Corp. Secretary
235 East 42Nd St.
New York NY 10017
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-08-03 100 $39.56 127,954 No 4 S Direct
Common Stock Disposition 2018-08-03 100 $39.52 127,854 No 4 S Direct
Common Stock Disposition 2018-08-03 2,100 $39.55 125,754 No 4 S Direct
Common Stock Disposition 2018-08-03 4,500 $39.53 121,254 No 4 S Direct
Common Stock Disposition 2018-08-03 6,400 $39.51 114,854 No 4 S Direct
Common Stock Disposition 2018-08-03 12,442 $39.50 102,412 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,120 Indirect By Rule 16b-3 Plan